Downregulation of oxytocin-related genes FOS, ITPR1, RCAN1, CAMK2D, and CACNA2D was observed in breast cancer samples, implying a correlation between the expression of this endogenous molecule and breast tumor malignancy (67). This evidence concerns the gene OXT and breast cancer.